Advances in the treatment of inflammatory arthritis

Best Practice and Research: Clinical Rheumatology

Volumn 26, Issue 2, 2012, Pages 251-261

  Pisetsky, David S ^a,b   Ward, Michael M ^c  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

Ankylosing spondylitis; Rheumatoid arthritis; Spondyloarthritis

Indexed keywords

ABATACEPT; ADALIMUMAB; AZATHIOPRINE; AZITHROMYCIN; CELECOXIB; CERTOLIZUMAB PEGOL; CORTICOSTEROID; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DOXYCYCLINE; ETANERCEPT; GLUCOCORTICOID; GOLIMUMAB; HYDROXYCHLOROQUINE; INFLIXIMAB; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RIFAMPICIN; RITUXIMAB; SALAZOSULFAPYRIDINE; TOCILIZUMAB; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR INHIBITOR; UNINDEXED DRUG;

ARTICLE; CARDIOTOXICITY; CLINICAL FEATURE; CYTOPENIA; DIAGNOSTIC PROCEDURE; DIGESTIVE SYSTEM ULCER; DISABILITY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION; INFLAMMATION; JOINT MALFORMATION; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TOXICITY; LOW DRUG DOSE; MEDICAL DECISION MAKING; NEPHROTOXICITY; PATHOGENESIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REACTIVE ARTHRITIS; REMISSION; RHEUMATOID ARTHRITIS; SPONDYLARTHRITIS; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUBERCULOSIS;

EID: 84863886860     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2012.03.001     Document Type: Review

References (55)

1. D.L. Scott, F. Wolfe, and T.W.J. Huizinga Rheumatoid arthritis Lancet 376 2010 1094 1108
2. M.J.H. Coenen, and P.K. Gregersen Rheumatoid arthritis: a view of the current genetic landscape Genes and Immunity 77 2008 1 11
3. G.D. Kitas, and S.E. Gabriel Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives Annals of the Rheumatic Diseases 70 2011 8 14
4. C. Ospelt, and S. Gay The role of resident synovial cells in destructive arthritis Best Practice & Research in Clinical Rheumatology 22 2008 239 252 (Pubitemid 351606943)
5. I.B. McInnes, and G. Schett Cytokines in the pathogenesis of rheumatoid arthritis Nature Reviews Immunology 7 2007 429 442 (Pubitemid 46834849)
6. R. Aggarwal, K. Liao, R. Nair, S. Ringold, and K.H. Costenbader Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis Arthritis Rheum 61 2009 1472 1483
7. G.J.M. Prujin, A. Wilk, and W.J. van Venrooij The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis Arthritis Research & Therapy 12 2010 1 8
8. H. Kallberg, B. Ding, L. Padyukov, C. Bengtsson, J. Rönnelid, and L. Lareskog Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke Ann Rheum Dis 70 2011 508 511
9. D. Aletaha, T. Neogi, A.J. Silman, J. Funovits, D.T. Felson, and C.O. Bingham 3rd 2010 Rheumatoid arthritis classification criteria Arthritis Rheum 62 2010 2569 2581
10. D.S. Majka, K.D. Deane, L.A. Parrish, A.A. Lazar, A.E. Baron, and C.W. Walker Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis Ann Rheum Dis 67 2008 801 807 (Pubitemid 351829380)
11. F. Joshua, M. Lassere, G.A. Bruyn, M. Szkudlarek, E. Naredo, and W.A. Schmidt Summary findings of a systematic review of the ultrasound assessment of synovitis J Rheumatol 34 2007 839 847 (Pubitemid 46641395)
12. A. Baillet, C. Gaujoux-Viala, G. Mouterde, T. Pham, J. Tebib, and A. Saraux Comparison of the efficacy of sonography, magnetic resonance imaging and conventional radiography for the detection of bone erosions in rheumatoid arthritis patients: a systematic review and meta analysis Rheumatology 50 2011 1137 1147
13. J.S. Smolen, D. Aletha, J.W. Bijlsma, F.C. Breedveld, D. Boumpas, and G. Burmester Treating rheumatoid arthritis to target: recommendations of an international task force Ann Rheum Dis 69 2010 631 637
14. D.T. Felson, J.S. Smolen, G. Wells, B. Zhang, L.H. van Tuyl, and J. Funovits American College of Rheumatology/European league against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials Ann Rheum Dis 70 2011 404 413
15. M.L. Prevoo, M.A. van't Hof, H.H. Kuper, M.A. van Leeuwen, L.B. van de Putte, and P.L. van Riel Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 1995 44 48
16. T. Pincus, M.J. Bergman, and Y. Yazici RAPID3 - an index of physical function, pain, and global status as "vital signs" to improve care for people with chronic rheumatic diseases Bulletin of NY Hospital for Joint Diseases 67 2009 211 225
17. J.R. O'Dell Therapeutic strategies for rheumatoid arthritis New England Journal of Medicine 350 2004 2591 2602
18. J.S. Smolen, D. Aletha, M. Koeller, M.H. Weisman, and P. Emery New therapies for treatment of rheumatoid arthritis Lancet 370 2007 1861 1874 (Pubitemid 350180008)
19. K.G. Saag, G.G. Teng, N.M. Patkar, J. Anuntiyo, C. Finney, and J.R. Curtis American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease- modifying antirheumatic drugs in rheumatoid arthritis Arthritis Rheum 59 2008 762 784 (Pubitemid 351847559)
20. Recommendations for use of selective and nonselective nonsteroidal anti-inflammatory drugs: an American College of Rheumatology white paper Arthritis and Rheumatism 59 2008 1058 1073
21. J.N. Hoes, J.W.G. Jacobs, F. Buttgereit, and J.W.J. Bijlsma Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis Nature Reviews Rheumatology 6 2010 693 702
22. J.M. Kremer Toward a better understanding of methotrexate Arthritis and Rheumatism 50 2004 1370 1382 (Pubitemid 38608058)
23. J.M. Bathon, R.W. Martin, R.M. Fleischmann, J.R. Tesser, M.H. Schiff, and E.C. Keystone A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis N Engl J Med 343 2000 1586 1593 (Pubitemid 32162981)
24. P.E. Lipsky, D.M. van der Heijde, E.W. St. Clair, D.E. Furst, F.C. Breedveld, and J.R. Kalden Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial iri rheumatoid arthritis with concomitant therapy study group N Engl J Med 342 2000 1594 1602
25. D. van der Heijde, L. Klareskog, R. Landewé, G.A. Bruyn, A. Cantagrel, and P. Durez Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis Arthritis Rheum 56 2007 3928 3939 (Pubitemid 350262318)
26. F.C. Breedveld, M.H. Weisman, A.F. Kavanaugh, S.B. Cohen, K. Pavelka, and R. van Vollenhoven The Premier Study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment Arthritis Rheum 54 2006 26 37 (Pubitemid 43122183)
27. R.B. Landewé, M. Boers, A.C. Verhoeven, R. Westhovens, M.A. van de Laar, and H.M. Markusse COBRA combination therapy in patients with early rheumatoid arthritis Arthritis Rheum 46 2002 347 356
28. C. Grigor, H. Capell, A. Stirling, A.D. McMahon, P. Lock, and R. Vallance Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single- blind randomized controlled trial Lancet 364 2004 263 269 (Pubitemid 38942816)
29. Y.P. Goekoop-Ruiterman, J.K. de Vries-Bouwstra, C.F. Allaart, D. van Zeben, P.J. Kerstens, and J.M. Hazes Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study) Arthritis Rheum 52 2005 3381 3390 (Pubitemid 41612204)
30. N.B. Klarenbeek, S.M. van der Kooij, M. Güler-Yuksel, J.H. van Groenendael, K.H. Han, and P.J. Kerstens Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the best study Ann Rheum Dis 70 2011 315 319
31. C.G. Helmick, D.T. Felson, R.C. Lawrence, S. Gabriel, R. Hirsch, and C.K. Kwoh Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part 1 Arthritis Rheum 58 2008 15 25
32. N. Akkoc Are spondyloarthropathies as common as rheumatoid arthritis worldwide? A review Current Rheumatology Reports 10 2008 371 378
33. S. van der Linden, H.A. Valkenburg, and A. Cats Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria Arthritis and Rheumatism 27 1984 361 368 (Pubitemid 14134775)
34. A.N. Bennett, D. McGonagle, P. O'Connor, E.M. Hensor, F. Sivera, and L.C. Coates Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years Arthritis Rheum 58 2008 3413 3418
35. M. Rudwaleit, D. van der Heijde, R. Landewe, J. Listing, N. Akkoc, and J. Brandt The development of Assessment of Spondyloarthritis International Society classification criteria for axial spondylarthritis (part II): validation and final selection Ann Rheum Dis 68 2009 777 783
36. M. Rudwaleit, H. Haibel, X. Baraliakos, J. Listing, E. Marker-Hermann, and H. Zeidler The early disease: stage in axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort Arthritis Rheum 60 2009 717 727
37. A. Calin, J. Porta, J.F. Fries, and D.J. Schurman Clinical history as a screening test for ankylosing spondylitis JAMA 237 1977 2613 2614 (Pubitemid 8104225)
38. M. Rudwaleit, A. Metter, J. Listing, J. Sieper, and J. Braun Inflammatory back pain in ankylosing spondylitis. A reassessment of the clinical history for application as classification and diagnostic criteria Arthritis and Rheumatism 54 2006 569 578 (Pubitemid 43228633)
39. J. Sieper, D. van der Heijde, R. Landewe, J. Brandt, R. Burgos-Vagas, and E. Collantes-Estevez New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of Spondyloarthritis International Society (ASAS) Ann Rheum Dis 68 2009 784 788
40. M. Rudwaleit, D. van der Heijde, R. Landewe, N. Akkoc, J. Brandt, and C.T. Chou The Assessment of Spondyloarthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general Ann Rheum Dis 70 2011 25 31
41. W. Taylor, D. Gladman, P. Helliwell, A. Marchesoni, P. Mease, and H. Mielants Classification criteria for psoriatic arthritis: Development of new criteria from a large international study Arthritis Rheum 54 2006 2665 2673 (Pubitemid 44205029)
42. S. D'Angelo, G.A. Mennillo, M.S. Cutro, P. Leccese, A. Nigro, and A. Padula Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis J Rheumatol 36 2009 368 370
43. S. Smale, R.S. Natt, T.R. Orchard, A.S. Russell, and I. Bjarnason Inflammatory bowel disease and spondyloarthropathy Arthritis Rheum 44 2001 2728 2736
44. M. de Vries, I. van der Horst-Bruinsma, I. van Hoogstraten, A. van Bodegraven, B.M. von Blomberg, and H. Ratnawati pANCA, ASCA, and OmpC antibodies in patients with ankylosing spondylitis without inflammatory bowel disease J Rheumatol 37 2010 2340 2344
45. Australo-Anglo-American Spondylitis Consortium (TASC), J.D. Reveille, A.M. Sims, P. Danoy, D.M. Evans, and P. Leo Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci Nat Genet 42 2010 123 127
46. S.Q. Crome, A.Y. Wang, and M.K. Levings Translational mini-review series on Th17 cells: Function and regulation of human T-helper 17 cells in health and disease Clinical and Experimental Immunology 159 2009 109 119
47. A. Franke, D.P. McGovern, and J.C. Barnett Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci Nature Genetics 42 2010 1118 1125
48. Genetic Analysis of Psoriasis Consortium Wellcome Trust Case Control Consortium 2 A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 Nature Genetics 42 2010 985 990
49. G. Tonel, C. Conrad, and U. Laggner A critical functional role of IL-23 in psoriasis Journal of Immunology 185 2010 5688 5691
50. C. Abraham, and J. Cho Interleukin-23/Th17 pathways and inflammatory bowel disease Inflammatory Bowel Diseases 15 2009 1090 1100
51. N. Putschky, H.G. Pott, J.G. Kuipers, H. Zeidler, M. Hammer, and J. Wollenhaupt Comparing 10- day and 4-month doxycycline courses for treatment of Chlamydia trachomatis-reactive arthritis: a prospective, double-blind trial Ann Rheum Dis 65 2006 1521 1524 (Pubitemid 44629134)
52. J.D. Carter, L.R. Espinoza, R.D. Inman, K.B. Sneed, L.R. Ricca, and F.B. Vasey Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis. A double-blind, placebo-controlled, prospective trial Arthritis Rheum 62 2010 1298 1307
53. V. Chandran, C.T. Schentag, and D.D. Gladman Reappraisal of the effectiveness of methotrexate in psoriatic arthritis: results from a longitudinal observational cohort Journal of Rheumatology 35 2008 469 471 (Pubitemid 351374423)
54. D. van der Heijde, R. Landewe, S. Einstein, P. Ory, D. Vosse, and L. Ni Radiographic progression of ankylosing spondylitis after up to 2 years of treatment with etanercept Arthritis Rheum 58 2008 1324 1331 (Pubitemid 351705922)
55. D. van der Heijde, R. Landewe, X. Baraliakos, H. Houben, A. van Tubergen, and P. Williamson Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis Arthritis Rheum 58 2008 3063 3070